0001709440-20-000003.txt : 20200124
0001709440-20-000003.hdr.sgml : 20200124
20200124152236
ACCESSION NUMBER: 0001709440-20-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200124
DATE AS OF CHANGE: 20200124
EFFECTIVENESS DATE: 20200124
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Plakous Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709440
IRS NUMBER: 812037804
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-358913
FILM NUMBER: 20545187
BUSINESS ADDRESS:
STREET 1: 755 HIGHLAND OAKS DRIVE
STREET 2: SUITE 103
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
BUSINESS PHONE: 336-782-3106
MAIL ADDRESS:
STREET 1: 755 HIGHLAND OAKS DRIVE
STREET 2: SUITE 103
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
D
1
primary_doc.xml
X0708
D
LIVE
0001709440
Plakous Therapeutics, Inc.
755 HIGHLAND OAKS DRIVE
SUITE 103
WINSTON-SALEM
NC
NORTH CAROLINA
27103
336-782-3106
NORTH CAROLINA
None
None
Corporation
true
2016
Scott
A.
Washburn
755 Highland Oaks Drive
Suite 103
Winston-Salem
NC
NORTH CAROLINA
27103
Executive Officer
Director
President
Seth
Tomblyn
755 Highland Oaks Drive
Suite 103
Winston-Salem
NC
NORTH CAROLINA
27103
Executive Officer
Director
Secretary and Treasurer
Peter
Johnson
755 Highland Oaks Drive
Suite 103
Winston-Salem
NC
NORTH CAROLINA
27103
Director
Allison
London
Brown
755 Highland Oaks Drive
Suite 103
Winston-Salem
NC
NORTH CAROLINA
27103
Director
Robert
W.
Boyce
755 Highland Oaks Drive
Suite 103
Winston-Salem
NC
NORTH CAROLINA
27103
Executive Officer
CEO
Biotechnology
Decline to Disclose
- 06b
false
2019-03-08
true
true
Convertible promissory notes
false
25000
4000000
175000
3825000
false
3
0
0
0
true
The proceeds will be used for working capital, which the issuer anticipates may include compensation (estimated to be approximately 12.5% of total proceeds) to named executive officers.
false
Plakous Therapeutics, Inc.
/s/ Scott A. Washburn
Scott A. Washburn
President
2020-01-24